Data Privacy & Protection

NYC Health and Hospitals Breach Affects 1.8 Million People
Tech & Innovation NYC Health and Hospitals Breach Affects 1.8 Million People

The recent security compromise within the New York City Health and Hospitals system has sent shockwaves through the metropolitan healthcare infrastructure, affecting approximately 1.8 million individuals and exposing a staggering depth of personal data. Investigators confirmed that while the

What Should You Know Before Joining a Clinical Trial?
Management & Regulatory What Should You Know Before Joining a Clinical Trial?

The rapid acceleration of medical breakthroughs in recent years has transformed clinical trials from a last-resort option into a sophisticated avenue for accessing cutting-edge healthcare solutions. These research studies represent the essential bridge between theoretical laboratory discoveries and

UK Mandates Centralized Single Patient Record for the NHS
Tech & Innovation UK Mandates Centralized Single Patient Record for the NHS

The fragmented landscape of the British healthcare system is currently undergoing a radical transformation as the government mandates a move toward a centralized Single Patient Record. This legislative shift aims to dismantle the long-standing silos that have historically prevented hospitals and

Birth Weight Predicts Kidney Resilience in Adult Athletes
Management & Regulatory Birth Weight Predicts Kidney Resilience in Adult Athletes

The physiological capacity of a modern ultramarathon runner might not be determined solely by thousands of grueling training miles but rather by the delicate window of biological development occurring within the final weeks of gestation. This revelation is fundamentally altering the landscape of

Media Habits and Political Views Drive MMR Vaccine Hesitancy
Tech & Innovation Media Habits and Political Views Drive MMR Vaccine Hesitancy

The once-vanquished threat of measles has returned to the forefront of the American medical landscape, signaling a profound breakdown in the shared reality that once underpinned collective public health safety. Health decisions are no longer made solely in consultation with a family doctor but are

EU Approves Enflonsia for Season-Long Infant RSV Prevention
Management & Regulatory EU Approves Enflonsia for Season-Long Infant RSV Prevention

Chloe Botaine sat down with Ivan Kairatov, a Biopharma expert with deep R&D and tech experience, to discuss the European Commission’s approval of a long-acting monoclonal antibody for RSV prevention in newborns and infants. With a single intramuscular dose designed to protect for up to five months,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later